Zhejiang Yongtai’s Recent Trading Performance

During the 24‑hour trading window that closed at 06:46 AM Central Europe on Wednesday, 21 November, Zhejiang Yongtai (002326.SZ) exhibited a flat movement, with its share price unchanged from the previous close. At the time of writing, one share was trading at approximately CNY 14.83 on the Shenzhen Stock Exchange. The stock remains highly liquid, with a current supply of 985.4 million shares and a market capitalization of CNY 14.8 billion. In the past day, investors exchanged roughly CNY 771.8 million worth of the company’s shares.

Since the end of last month, Zhejiang Yongtai’s price has fallen by 13.12 %. The 200‑day simple moving average stands at CNY 19.77, suggesting that the stock is trading well below its medium‑term trend. The 52‑week high of CNY 33 was reached on 18 November 2025, while the recent 52‑week low of CNY 14.89 was recorded on 19 October 2026. These figures place the current price near the bottom of its annual range, indicating a potential for upside if the company’s fundamentals remain solid.

Market Context and Peer Comparison

The broader sector has shown a similar pattern of stability. The following key competitors were also flat over the same 24‑hour period:

  • Zhuhai Bojay Electronics C (002975.SZ) – CNY 88.51, market cap CNY 17.6 billion, P/E 83.64.
  • Zhejiang Jiuli Hi-tech (002318.SZ) – CNY 18.17, market cap CNY 17.6 billion, P/E 16.05.
  • Weifu High (000581.SZ) – CNY 18.04, market cap CNY 17.7 billion, P/E 14.63.
  • Sichuan Hebang Biotechnol (603077.SS) – CNY 2.10, market cap CNY 17.7 billion.
  • Sichuan Gold (001337.SZ) – CNY 42.79, market cap CNY 17.7 billion.

While all these stocks remained unchanged, Zhejiang Yongtai’s valuation remains comparatively attractive, especially when considering its price‑to‑earnings ratio and the breadth of its product portfolio.

Company Overview

Zhejiang Yongi Technology Co., Ltd., headquartered in Taizhou, China, focuses on the research, development, manufacturing, and distribution of fluorine‑containing fine chemicals. Its product line spans pharmaceuticals targeting cardiovascular disease, diabetes, central nervous system disorders, anti‑infection, and anti‑viral conditions, alongside agricultural chemicals such as herbicides and fungicides. In addition, the company produces lithium‑battery materials, positioning it at the intersection of healthcare and clean‑energy technology.

The firm first entered the public market on 22 December 2009 and continues to trade on the Shenzhen Stock Exchange. Investors interested in a deeper dive into Zhejiang Yongtai’s operations, financial statements, and strategic initiatives may consult the company’s website at www.yongitech.com .

In summary, Zhejiang Yongtai’s recent flat trading day reflects a broader sectoral pause, but the company’s robust market position, diversified product portfolio, and proximity to its 52‑week low suggest potential upside for investors who value long‑term growth prospects within the fine‑chemicals and pharmaceutical niche.